Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients

Despite effective factor replacement and various treatment schedules, there remain several challenges and unmet needs in the prophylactic treatment of hemophilia limiting its adoption and thereby posing an increased risk...

Congenital Diaphragmatic Hernia and Iron Defi ciency Anemia

To the Editor, The case described by Dr. Sarper and her colleagues in their letter to the editor, entitled “Severe iron defi ciency anemia due to late presentation of congenital diaphragmatic hernia in a toddler”, was n...

An Updated Review of Abnormal Hemoglobins in the Turkish Population

First Observation of Hb South Florida [beta 1(NA1) Val>Met] in Turkey

To the Editor, Hemoglobin (Hb) South Florida [beta1(NA1) Val>Met] is a rare beta hemoglobin variant that was fi rst reported in 1985 from South Florida [1,2]. We report here, for the fi rst time in Turkey, a 17-year-...

Rituximab-Related Reversible Hepatocellular Damage

To the Editor, Since its approval in 1997 by the US Food and Drug Administration, use of rituximab (MabThera®, Roche,Switzerland) has become widespread, especially for the treatment of non-Hodgkin lymphoma (NHL) and chr...